Skip to main content

#161918

SK-MEL-3 Cell Line

Cat. #161918

SK-MEL-3 Cell Line

Cat. #: 161918

Availability: 8-10 weeks

Organism: Human

Tissue: Skin

Model: Tumourigenic

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Lloyd J. Old, Germain Trempe

Institute: Memorial Sloan-Kettering Cancer Center (MSK)

Primary Citation: Fogh et al. 1977. Journal of the National Cancer Institute. 59: 221-226. PMID: 327080.

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: SK-MEL-3 Cell Line
  • Cancer: Skin cancer
  • Organism: Human
  • Gender: Female
  • Tissue: Skin
  • Donor: This cell line was established in 1972 from a metastatic site (lymph node) in a 42-year-old Caucasian female with malignant melanoma.
  • Morphology: Fibroblast
  • Growth properties: Adherent
  • Model: Tumourigenic
  • Model description: Tumourigenic in nude mice; forms pigmented malignant melanoma
  • Products or characteristics of interest: Karyotype: (P13) hypotetraploid to hypertetraploid with abnormalities including dicentrics, pulverizations, secondary constrictions and minutes. Isoenzymes: AK-1, 1; ES-D, 1; G6PD, B; GLO-I, 1-2; PGM1, 1-2; PGM3, 1
  • Description: SK-MEL-3 is one of a series of melanoma cell lines established from patient-derived tumour samples. This cell line is known to form tumours in immunocompromised mice.
  • Application: 3D cell culture; High-throughput screening; Toxicology
  • Biosafety level: 1

Target Details

  • Target: Antigen expression: Blood Type O; Rh+

Applications

  • Application: 3D cell culture; High-throughput screening; Toxicology

Handling

  • Growth medium: McCoy's 5a Medium Modified supplemented with FBS to a final concentration of 15%
  • Temperature: 37° C
  • Atmosphere: 5% CO2 in air
  • Shipping conditions: Dry Ice
  • Storage medium: Complete growth medium supplemented with 5% (v/v) DMSO
  • Storage conditions: Vapor phase of liquid nitrogen
  • Subculture routine: Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. Remove and discard culture medium. Briefly rinse the cell layer with 0.25% (w/v) Trypsin-0.53mM EDTA solution to remove all traces of serum, which contains trypsin inhibitor. Add 2.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping do not agitate the
  • Str profiling: Amelogenin: XCSF1PO: 9,10D13S317: 12,13D16S539: 11D5S818: 11D7S820: 8,10TH01: 6TPOX: 8vWA: 14,18D3S1358: 17,18D21S11: 29,30D18S51: 10,18Penta_E: 11,15Penta_D: 9,13D8S1179: 14FGA: 24D19S433: 15,16.2D2S1338: 19,23

References

  • Fogh et al. 1977. Journal of the National Cancer Institute. 59: 221-226. PMID: 327080.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.